Aidoc launches the first ai-based automated notification solution for high-risk pulmonary embolism patients
The workflow-integrated solution developed in collaboration with Yale radiologists expedites time-sensitive decision-making and improves quality of care.
Aidoc, the leading provider of enterprise AI solutions, announced today the launch of an industry first: an AI-based automated activation solution that facilitates rapid risk assessment and care coordination for high-risk pulmonary embolism (PE) patients.
Aidoc’s PE Care Coordination includes Aidoc’s FDA-cleared solution for triage and notification of PE. The solution is “Always-on”, running behind the scenes and does not require physician activation. High-risk PE patients are automatically flagged after the scan is performed and a notification is sent simultaneously to all the relevant team members, including radiologists, pulmonologists, cardiologists and vascular surgeons. Once the teams are alerted, the solution enables real-time image, data and text sharing leading to improved patient management and care coordination.
The launch is part of an ongoing Aidoc partnership with the Department of Radiology and Biomedical Imaging at Yale School of Medicine and follows six months of clinical use led by the Yale radiology team.
“We have been using the first version of this solution for the last six months and have seen the real impact this has had on addressing patients that require treatment beyond anticoagulation,” said Dr. Irena Tocino, Professor and Vice Chair of Medical Informatics in the department of Radiology & Biomedical Imaging at Yale School of Medicine (YSM). “Having this subset of patients routed simultaneously to multiple stakeholders has shown a reduction in time to treatment and clear improvements in patient outcomes.”
“The PE Response Team (PERT) was established to provide rapid risk assessment along with execution of the patient management strategy,” said Dr. Akhil Khosla, co-director of the PERT program, in the department of Internal Medicine at YSM. “One of the challenges of establishing a PERT program is making sure the right information is in the hands of the right clinician. In Aidoc, we have a partner with the ability to bring deep integration of AI into these native workflows. The outcome leads to enhanced patient eligibility for novel therapies and makes a significant change to patient management.” PE outcomes are highly variable. While some patients have excellent prognosis without any treatment, others may require invasive and urgent therapies. Rapid risk assessment of acute PE cases is essential for the triage of patients, and a multidisciplinary approach to patient treatment and management can be the defining factor in their care.
Related news
-
The Indoor Microbiome and Its Impact on Indoor Environmental Quality
Last year, the U.S. Environmental Protection Agency (EPA) announced the release of a new webpage to provide information about the indoor microbiome. All of the living microorganisms inside of an indoor environment, and their by-products, are collectively known as the indoor microbiome. The indoor microbiome that surrounds each of us is diverse and dynamic, made up of bacteria, viruses, fungi and other single-celled organisms. These microorganisms may be growing or inactive, and may be present in different life...
-
The Chinese University of Hong Kong and Aurora Medical Technology Hong Kong to collaborate on breast cancer research program
Aurora Medical Technology Hong Kong (Aurora-HK) and The Chinese University of Hong Kong (CUHK) are pleased to announce the completion of a landmark collaboration agreement leveraging the shared interests and diverse expertise of the two entities.Led by Winnie chiu-wing Chu MD, Professor of radiology at CUHK and Abraham Morse MD, Medical Director of Aurora, the joint project will investigate the potential advantages and challenges of using breast-dedicated MRI for first-line breast cancer screening in Chinese...
-
Radiology partners selects Aidoc to Accelerate the use of AI as the standard of Care in Radiology
Radiology Partners (RP), the leading radiology practice in the U.S., announced today that it has selected Aidoc, the leading provider of artificial intelligence (AI) solutions for medical imaging, to offer unparalleled AI capabilities to its hospitals and health systems, and to accelerate the adoption of AI as the standard of care in radiology. “AI has the potential to unlock enormous value for the entire healthcare ecosystem, and I believe our partnership with Aidoc will turn out to be the tipping point...
-
Nanox and USARAD Introduce Radiology AI Second Opinion Program
NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announces an extension of its strategic collaboration with USARAD Holdings Inc., a US Joint Commission accredited teleradiology and telemedicine company, to launch an advanced radiology diagnostics service combining over 300 expert radiologists and artificial intelligence (AI) decision support algorithms and solutions. In February 2020, Nanox and USARAD originally announced...
-
AIDOC and IMBIO partner to provide an industry first ai solution to prioritize suspected pulmonary embolism and automatically calculate RV/LV ratio
Aidoc, the leading provider of enterprise AI solutions, and Imbio, a leading provider of medical image analysis for pulmonary and cardiothoracic diseases, announced today a partnership intended to provide the world’s first end-to-end AI solution for pulmonary embolism (PE), with the goal of ultimately improving efficiency and quality of pulmonary embolism detection and treatment. “Achieving the value of AI in clinical practice requires end-to-end solutions which consolidate the various AI results and...
Customer comments
No comments were found for Aidoc launches the first ai-based automated notification solution for high-risk pulmonary embolism patients. Be the first to comment!